These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20136479)

  • 1. Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotension.
    Minns AB; Clark RF; Schneir A
    Clin Toxicol (Phila); 2010 Feb; 48(2):146-8. PubMed ID: 20136479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overdose of extended-release guanfacine.
    Fein DM; Hafeez ZF; Cavagnaro C
    Pediatr Emerg Care; 2013 Aug; 29(8):929-31. PubMed ID: 23925253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
    Boon-yasidhi V; Kim YS; Scahill L
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S156-62. PubMed ID: 16856436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syncope in children with Tourette's syndrome treated with guanfacine.
    King A; Harris P; Fritzell J; Kurlan R
    Mov Disord; 2006 Mar; 21(3):419-20. PubMed ID: 16229000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanfacine for Tourette's disorder.
    Fras I
    J Am Acad Child Adolesc Psychiatry; 1996 Jan; 35(1):3-4. PubMed ID: 8567607
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of guanfacine toxicity with naloxone.
    Tsze DS; Dayan PS
    Pediatr Emerg Care; 2012 Oct; 28(10):1060-1. PubMed ID: 23034493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
    Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
    Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated atomoxetine overdose resulting in seizure.
    Kashani J; Ruha AM
    J Emerg Med; 2007 Feb; 32(2):175-8. PubMed ID: 17307628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular parameters of heroin-withdrawn addicts treated with guanfacine.
    Rubio G; Alguacil LF; Alamo C; López-Muñoz F; Pascual J; López-Trabada JR
    Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):189-92. PubMed ID: 9203168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged bradycardia and hypotension following guanfacine extended release overdose.
    Walton J; Byrum M; Shumaker A; Coury DL
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):463-5. PubMed ID: 25010857
    [No Abstract]   [Full Text] [Related]  

  • 12. Does guanfacine trigger mania in children?
    Horrigan JP; Barnhill LJ
    J Child Adolesc Psychopharmacol; 1998; 8(2):149-50. PubMed ID: 9730081
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric ziprasidone overdose.
    Fasano CJ; O'Malley GF; Lares C; Rowden AK
    Pediatr Emerg Care; 2009 Apr; 25(4):258-9. PubMed ID: 19369840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanfacine toxic ingestion with subsequent cardiogenic pulmonary edema.
    Bridwell RE; Larson NP; Rosenthal JB; Wray J; Baker Z; Cibrario A; Oliver JJ
    Am J Emerg Med; 2021 Jan; 39():256.e5-256.e8. PubMed ID: 33069545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanfacine use in children with attention deficit hyperactivity disorder.
    Cohn LM; Caliendo GC
    Ann Pharmacother; 1997; 31(7-8):918-9. PubMed ID: 9220058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sulpiride poisoning--case report confirmed with the quantitative determination of the xenobiotic serum level].
    Ciszowski K; Szpak D; Wilimowska J; Groszek B
    Przegl Lek; 2011; 68(8):506-9. PubMed ID: 22010451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanfacine in children with autism and/or intellectual disabilities.
    Handen BL; Sahl R; Hardan AY
    J Dev Behav Pediatr; 2008 Aug; 29(4):303-8. PubMed ID: 18552703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Orthostatic hypotension with syncope--a problem of hypertensive therapy in the aged].
    Trenkwalder P; Lydtin H
    Z Gerontol; 1993; 26(4):297-301. PubMed ID: 8212801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric effects of guanfacine in children with mild tourette syndrome: a pilot study.
    Cummings DD; Singer HS; Krieger M; Miller TL; Mahone EM
    Clin Neuropharmacol; 2002; 25(6):325-32. PubMed ID: 12469007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.